Evolent Health, Inc. (EVH)

Market Cap	3.41B
Revenue (ttm)	1.96B
Net Income (ttm)	-142.26M
Shares Out	115.43M
EPS (ttm)	-1.28
PE Ratio	n/a
Forward PE	24.30
Dividend	n/a
Ex-Dividend Date	n/a

Volume	156,160
Open	29.56
Previous Close	29.62
Day's Range	29.33 - 29.73
52-Week Range	23.33 - 36.70
Beta	1.54
Analysts	Buy
Price Target	42.63 (+44.61%)
Earnings Date	May 9, 2024

About EVH

Evolent Health, Inc., through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care wor...

• Industry: Health Information Services
• Sector: Healthcare
• IPO Date: Jun 5, 2015
• Employees: 4,700
• Stock Exchange: NYSE
• Ticker Symbol: EVH

Financial Performance

In 2023, Evolent Health's revenue was $1.96 billion, an increase of 45.26% compared to the previous year's $1.35 billion. Losses were -$142.26 million, 642.3% more than in 2022.

Analyst Forecast

According to 8 analysts, the average rating for EVH stock is "Buy." The 12-month stock price forecast is $42.63, which is an increase of 44.61% from the latest price.

Price Target

$42.63

(44.61% upside)

Analyst Consensus: Buy